Skip to content
Screener

Reported November 12, 2026 · Before market open

Revenue$19.6MBeat by $740.4K
EPS$0.12Beat by $0.02
Revenue estimate$18.9M
EPS estimate$0.10

Next report

Date not yet announced

FAQ

When did Fennec Pharmaceuticals report Q3 2026 earnings?
Fennec Pharmaceuticals (FENC) reported Q3 2026 earnings on November 12, 2026 before market open.
What were Fennec Pharmaceuticals's Q3 2026 revenue and EPS?
Fennec Pharmaceuticals reported revenue of $19.6M and eps of $0.12 for Q3 2026.
Did Fennec Pharmaceuticals beat estimates in Q3 2026?
Revenue beat the consensus estimate of $18.9M by $740.4K. EPS beat the consensus estimate of $0.10 by $0.02.
How did Fennec Pharmaceuticals's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 57.3% from $12.5M a year earlier.
Where can I find Fennec Pharmaceuticals's Q3 2026 SEC filings?
You can read the 10-Q periodic report (0001104659-26-126203) directly on SEC EDGAR. The filing index links above go to sec.gov.